Yanping Xu

发表

Design and synthesis of a potent and selective triazolone-based peroxisome proliferator-activated receptor alpha agonist.

C. Montrose‐Rafizadeh, R. Thompson, W. Bensch, 2003, Journal of medicinal chemistry.

Design and synthesis of a potent and selective triazolone-based peroxisome proliferator-activated receptor α agonist

C. Montrose‐Rafizadeh, R. Thompson, W. Bensch, 2003 .

Design and synthesis of alpha-aryloxy-alpha-methylhydrocinnamic acids: a novel class of dual peroxisome proliferator-activated receptor alpha/gamma agonists.

G. Stephenson, K. Ogilvie, L. L. Winneroski, 2004, Journal of medicinal chemistry.

Recent Progress on Bile Acid Receptor Modulators for Treatment of Metabolic Diseases.

Yanping Xu, 2016, Journal of medicinal chemistry.

Bile Acid Receptor Modulators in Metabolic Diseases

Yanping Xu, 2011 .

Conversion of human-selective PPARalpha agonists to human/mouse dual agonists: a molecular modeling analysis.

R. Babine, K. Ogilvie, L. L. Winneroski, 2004, Bioorganic & medicinal chemistry letters.

Peroxisome proliferator activated receptor agonists

L. L. Winneroski, R. Thompson, Yanping Xu, 1997 .

Design and synthesis of novel and potent amide linked PPARγ/δ dual agonists

Michael E. Laurila, L. L. Winneroski, G. Etgen, 2007 .

Design and synthesis of dual peroxisome proliferator-activated receptors γ and δ agonists as novel euglycemic agents with a reduced weight gain profile

L. L. Winneroski, G. Etgen, C. Broderick, 2006 .

Design and synthesis of dual peroxisome proliferator-activated receptors gamma and delta agonists as novel euglycemic agents with a reduced weight gain profile.

L. L. Winneroski, G. Etgen, C. Broderick, 2006, Journal of medicinal chemistry.